Country for PR: China
Contributor: Xinhua News Agency
Thursday, April 22 2021 - 19:36
AsiaNet
Wuxi Strives to Build a World-class Biomedical Industry Chain
WUXI, China, April 22, 2021 /Xinhua-AsiaNet/--

From April 21 to 23, the 2021 Taihu Bay Future Healthcare Conference was held 
in Wuxi, China. More than 160 experts including Hejie, Fan Chunhai and many 
other academicians carried out forward-looking, authoritative, and predictive 
exchanges and dialogues on topics such as industrial investment and 
cooperation, medical collaborative ecology, and intelligent medical trends, 
according to Wuxi Science and Technology Bureau.
 
This conference is a landmark event in the development of Wuxi's biomedical 
industry.  Huang Qin, Secretary of Wuxi Municipal Committee of the CPC, said 
that Wuxi regards the biomedical industry as a strategic emerging industry that 
is key to its development, and strives to build a world-class industrial chain.
 
In recent years, Wuxi's biomedical industry has developed rapidly. This 
benefits from a good industrial foundation and historical endowment. It is also 
related to the local government's strategy and the pioneering spirit of the 
local people since the 1990s.
 
Du Xiaogang, Mayor of Wuxi personally serves as the "chain leader" of the 
biomedical industry chain. At present, Wuxi has gathered more than 1,000 
biomedical companies such as AstraZeneca and WuXi AppTec. The scale of the 
industry has exceeded 100 billion yuan. The target is 250 billion yuan in 2025.
 
In 2019, Wuxi and AstraZeneca cooperated to build the "Wuxi International Life 
Science Innovation Park" (I Campus). This innovative cooperation model based on 
enterprise leadership and market driving has injected new vitality into the 
in-depth construction of the industrial chain. There are 4 such biomedical 
industrial parks in Wuxi, with a professional platform of 860,000 square meters.
 
In the future, Wuxi will concentrate its efforts to increase R&D investment, 
create two international leading innovation centers for innovative drug 
discovery and health food, and build an innovation cluster for the three major 
industries of high-end medical equipment, precision medicine, and digital 
medicine.
 
With the gradual maturity of the "No. 1 Project" Taihu Bay Science and 
Technology Innovation Center built by Wuxi, an internationally influential 
biomedical industry cluster will emerge here.

Source: Wuxi Science and Technology Bureau
Translations

German

Japanese

Korean